| Product Code: ETC9940280 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Carrier Screening Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Carrier Screening Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Carrier Screening Market - Industry Life Cycle |
3.4 United Kingdom (UK) Carrier Screening Market - Porter's Five Forces |
3.5 United Kingdom (UK) Carrier Screening Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 United Kingdom (UK) Carrier Screening Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 United Kingdom (UK) Carrier Screening Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F |
3.8 United Kingdom (UK) Carrier Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 United Kingdom (UK) Carrier Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Carrier Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about genetic disorders and the importance of carrier screening |
4.2.2 Technological advancements in genetic testing leading to more accurate and affordable screening options |
4.2.3 Growing prevalence of genetic disorders in the UK population |
4.3 Market Restraints |
4.3.1 High cost associated with carrier screening tests may limit adoption rates |
4.3.2 Lack of reimbursement policies for carrier screening tests in the UK healthcare system |
4.3.3 Ethical concerns and privacy issues related to genetic testing may deter some individuals from undergoing carrier screening |
5 United Kingdom (UK) Carrier Screening Market Trends |
6 United Kingdom (UK) Carrier Screening Market, By Types |
6.1 United Kingdom (UK) Carrier Screening Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Molecular Screening Test, 2021- 2031F |
6.1.4 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Biochemical Screening Test, 2021- 2031F |
6.2 United Kingdom (UK) Carrier Screening Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.3 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Tay-Sachs, 2021- 2031F |
6.2.4 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Gaucher Disease, 2021- 2031F |
6.2.5 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Sickle Cell Disease, 2021- 2031F |
6.2.6 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Spinal Muscular Atrophy, 2021- 2031F |
6.2.7 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Other Autosomal Recessive Genetic Disorders, 2021- 2031F |
6.3 United Kingdom (UK) Carrier Screening Market, By Medical Condition |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Pulmonary Conditions, 2021- 2031F |
6.3.3 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Hematological Conditions, 2021- 2031F |
6.3.4 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Neurological Conditions, 2021- 2031F |
6.3.5 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Carrier Screening Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By DNA Sequencing, 2021- 2031F |
6.4.3 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Polymerase Chain Reaction, 2021- 2031F |
6.4.4 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Microarrays, 2021- 2031F |
6.4.5 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Carrier Screening Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Reference Laboratories, 2021- 2031F |
6.5.4 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Physician Offices and Clinics, 2021- 2031F |
6.5.5 United Kingdom (UK) Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Carrier Screening Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Carrier Screening Market Export to Major Countries |
7.2 United Kingdom (UK) Carrier Screening Market Imports from Major Countries |
8 United Kingdom (UK) Carrier Screening Market Key Performance Indicators |
8.1 Rate of adoption of carrier screening tests in the UK population |
8.2 Number of healthcare providers offering carrier screening services |
8.3 Patient satisfaction and feedback on carrier screening services |
8.4 Number of research studies and publications on carrier screening in the UK |
9 United Kingdom (UK) Carrier Screening Market - Opportunity Assessment |
9.1 United Kingdom (UK) Carrier Screening Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 United Kingdom (UK) Carrier Screening Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 United Kingdom (UK) Carrier Screening Market Opportunity Assessment, By Medical Condition, 2021 & 2031F |
9.4 United Kingdom (UK) Carrier Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 United Kingdom (UK) Carrier Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Carrier Screening Market - Competitive Landscape |
10.1 United Kingdom (UK) Carrier Screening Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Carrier Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here